Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 199 of 199 entries
Sorted by: Best Match Show Resources per page
Formation of Catalytic Active Sites in Hydrothermally Obtained Binary Ceria-Iron Oxides: Composition and Preparation Effects.

ACS applied materials & interfaces

Tsoncheva T, Rosmini C, Dimitrov M, Issa G, Henych J, Němečková Z, Kovacheva D, Velinov N, Atanasova G, Spassova I.
PMID: 33320516
ACS Appl Mater Interfaces. 2021 Jan 13;13(1):1838-1852. doi: 10.1021/acsami.0c16326. Epub 2020 Dec 15.

A series of mesoporous cerium-iron binary oxides was prepared by a hydrothermal technique using CTAB as a template. The influence of the Fe/Ce ratio and the variations in the preparation techniques such as the type of solvent and the...

Cite
Tsoncheva T, Rosmini C, Dimitrov M, et al. Formation of Catalytic Active Sites in Hydrothermally Obtained Binary Ceria-Iron Oxides: Composition and Preparation Effects. ACS Appl Mater Interfaces. 2020;13(1):1838-1852doi: 10.1021/acsami.0c16326.
Tsoncheva, T., Rosmini, C., Dimitrov, M., Issa, G., Henych, J., Němečková, Z., Kovacheva, D., Velinov, N., Atanasova, G., & Spassova, I. (2021). Formation of Catalytic Active Sites in Hydrothermally Obtained Binary Ceria-Iron Oxides: Composition and Preparation Effects. ACS applied materials & interfaces, 13(1), 1838-1852. https://doi.org/10.1021/acsami.0c16326
Tsoncheva, Tanya, et al. "Formation of Catalytic Active Sites in Hydrothermally Obtained Binary Ceria-Iron Oxides: Composition and Preparation Effects." ACS applied materials & interfaces vol. 13,1 (2021): 1838-1852. doi: https://doi.org/10.1021/acsami.0c16326
Tsoncheva T, Rosmini C, Dimitrov M, Issa G, Henych J, Němečková Z, Kovacheva D, Velinov N, Atanasova G, Spassova I. Formation of Catalytic Active Sites in Hydrothermally Obtained Binary Ceria-Iron Oxides: Composition and Preparation Effects. ACS Appl Mater Interfaces. 2021 Jan 13;13(1):1838-1852. doi: 10.1021/acsami.0c16326. Epub 2020 Dec 15. PMID: 33320516.
Copy Download .nbib Format: NLM
Delta- and theta-band cortical tracking and phase-amplitude coupling to sung speech by infants.

NeuroImage

Attaheri A, Choisdealbha ÁN, Di Liberto GM, Rocha S, Brusini P, Mead N, Olawole-Scott H, Boutris P, Gibbon S, Williams I, Grey C, Flanagan S, Goswami U.
PMID: 34798233
Neuroimage. 2021 Nov 16;118698. doi: 10.1016/j.neuroimage.2021.118698. Epub 2021 Nov 16.

The amplitude envelope of speech carries crucial low-frequency acoustic information that assists linguistic decoding at multiple time scales. Neurophysiological signals are known to track the amplitude envelope of adult-directed speech (ADS), particularly in the theta-band. Acoustic analysis of infant-directed...

Cite
Attaheri A, Choisdealbha ÁN, Di Liberto GM, et al. Delta- and theta-band cortical tracking and phase-amplitude coupling to sung speech by infants. Neuroimage. 2021;118698doi: 10.1016/j.neuroimage.2021.118698.
Attaheri, A., Choisdealbha, �. �. N., Di Liberto, G. M., Rocha, S., Brusini, P., Mead, N., Olawole-Scott, H., Boutris, P., Gibbon, S., Williams, I., Grey, C., Flanagan, S., & Goswami, U. (2021). Delta- and theta-band cortical tracking and phase-amplitude coupling to sung speech by infants. NeuroImage, 118698. https://doi.org/10.1016/j.neuroimage.2021.118698
Attaheri, Adam, et al. "Delta- and theta-band cortical tracking and phase-amplitude coupling to sung speech by infants." NeuroImage vol. (2021): 118698. doi: https://doi.org/10.1016/j.neuroimage.2021.118698
Attaheri A, Choisdealbha ÁN, Di Liberto GM, Rocha S, Brusini P, Mead N, Olawole-Scott H, Boutris P, Gibbon S, Williams I, Grey C, Flanagan S, Goswami U. Delta- and theta-band cortical tracking and phase-amplitude coupling to sung speech by infants. Neuroimage. 2021 Nov 16;118698. doi: 10.1016/j.neuroimage.2021.118698. Epub 2021 Nov 16. PMID: 34798233.
Copy Download .nbib Format: NLM
Nickel-Decorated Mesoporous Iron-Cerium Mixed Oxides: Microstructure and Catalytic Activity in Methanol Decomposition.

ACS applied materials & interfaces

Tsoncheva T, Rosmini C, Mihaylov M, Henych J, Chakarova K, Velinov N, Kovacheva D, Němečková Z, Kormunda M, Ivanova R, Spassova I, Hadjiivanov K.
PMID: 34932905
ACS Appl Mater Interfaces. 2022 Jan 12;14(1):873-890. doi: 10.1021/acsami.1c19584. Epub 2021 Dec 21.

Nickel-decorated mesoporous cerium-iron oxide composites were synthesized by a combination of incipient wetness impregnation and template-assisted hydrothermal techniques. The effects of the Fe/Ce ratio and the calcination temperature of cerium-iron oxides on the phase composition, texture, structure, and redox...

Cite
Tsoncheva T, Rosmini C, Mihaylov M, et al. Nickel-Decorated Mesoporous Iron-Cerium Mixed Oxides: Microstructure and Catalytic Activity in Methanol Decomposition. ACS Appl Mater Interfaces. 2021;14(1):873-890doi: 10.1021/acsami.1c19584.
Tsoncheva, T., Rosmini, C., Mihaylov, M., Henych, J., Chakarova, K., Velinov, N., Kovacheva, D., Němečková, Z., Kormunda, M., Ivanova, R., Spassova, I., & Hadjiivanov, K. (2022). Nickel-Decorated Mesoporous Iron-Cerium Mixed Oxides: Microstructure and Catalytic Activity in Methanol Decomposition. ACS applied materials & interfaces, 14(1), 873-890. https://doi.org/10.1021/acsami.1c19584
Tsoncheva, Tanya, et al. "Nickel-Decorated Mesoporous Iron-Cerium Mixed Oxides: Microstructure and Catalytic Activity in Methanol Decomposition." ACS applied materials & interfaces vol. 14,1 (2022): 873-890. doi: https://doi.org/10.1021/acsami.1c19584
Tsoncheva T, Rosmini C, Mihaylov M, Henych J, Chakarova K, Velinov N, Kovacheva D, Němečková Z, Kormunda M, Ivanova R, Spassova I, Hadjiivanov K. Nickel-Decorated Mesoporous Iron-Cerium Mixed Oxides: Microstructure and Catalytic Activity in Methanol Decomposition. ACS Appl Mater Interfaces. 2022 Jan 12;14(1):873-890. doi: 10.1021/acsami.1c19584. Epub 2021 Dec 21. PMID: 34932905.
Copy Download .nbib Format: NLM
Perceived Onset Time of Medical Conditions: The Interplay Between Subjective Fear and Risk in Four Lifestyle Domains.

Psychological reports

Monzani D, Pancani L, Rusconi P, Pravettoni G.
PMID: 34324370
Psychol Rep. 2021 Jul 29;332941211036028. doi: 10.1177/00332941211036028. Epub 2021 Jul 29.

Engaging in unhealthy behaviors (e.g., smoking, drinking) and not engaging in healthy ones (e.g., exercising, consuming fruit and vegetables) are both relatively prevalent among individuals despite the available information about their risks for health. People's perception of an event's...

Cite
Monzani D, Pancani L, Rusconi P, et al. Perceived Onset Time of Medical Conditions: The Interplay Between Subjective Fear and Risk in Four Lifestyle Domains. Psychol Rep. 2021;332941211036028doi: 10.1177/00332941211036028.
Monzani, D., Pancani, L., Rusconi, P., & Pravettoni, G. (2021). Perceived Onset Time of Medical Conditions: The Interplay Between Subjective Fear and Risk in Four Lifestyle Domains. Psychological reports, 332941211036028. https://doi.org/10.1177/00332941211036028
Monzani, Dario, et al. "Perceived Onset Time of Medical Conditions: The Interplay Between Subjective Fear and Risk in Four Lifestyle Domains." Psychological reports vol. (2021): 332941211036028. doi: https://doi.org/10.1177/00332941211036028
Monzani D, Pancani L, Rusconi P, Pravettoni G. Perceived Onset Time of Medical Conditions: The Interplay Between Subjective Fear and Risk in Four Lifestyle Domains. Psychol Rep. 2021 Jul 29;332941211036028. doi: 10.1177/00332941211036028. Epub 2021 Jul 29. PMID: 34324370.
Copy Download .nbib Format: NLM
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.

Cancer discovery

Wu HC, Rérolle D, Berthier C, Hleihel R, Sakamoto T, Quentin S, Benhenda S, Morganti C, Wu C, Conte L, Rimsky S, Sebert M, Clappier E, Souquere S, Gachet S, Soulier J, Durand S, Trowbridge JJ, Bénit P, Rustin P, Hajj HE, Raffoux E, Ades L, Itzykson R, Dombret H, Fenaux P, Espeli O, Kroemer G, Brunetti L, Mak TW, Lallemand-Breitenbach V, Bazarbachi A, Falini B, Ito K, Martelli MP, de Thé H.
PMID: 34301789
Cancer Discov. 2021 Jul 23; doi: 10.1158/2159-8290.CD-21-0177. Epub 2021 Jul 23.

Acute myeloid leukemia (AML) pathogenesis often involves a mutation in the NPM1 nucleolar chaperone, but the bases for its transforming properties and overall association with favorable therapeutic responses remain incompletely understood. Here we demonstrate that an oncogenic mutant form...

Cite
Wu HC, Rérolle D, Berthier C, et al. Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy. Cancer Discov. 2021;doi: 10.1158/2159-8290.CD-21-0177.
Wu, H. C., Rérolle, D., Berthier, C., Hleihel, R., Sakamoto, T., Quentin, S., Benhenda, S., Morganti, C., Wu, C., Conte, L., Rimsky, S., Sebert, M., Clappier, E., Souquere, S., Gachet, S., Soulier, J., Durand, S., Trowbridge, J. J., Bénit, P., Rustin, P., Hajj, H. E., Raffoux, E., Ades, L., Itzykson, R., Dombret, H., Fenaux, P., Espeli, O., Kroemer, G., Brunetti, L., Mak, T. W., Lallemand-Breitenbach, V., Bazarbachi, A., Falini, B., Ito, K., Martelli, M. P., & de Thé, H. (2021). Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy. Cancer discovery, . https://doi.org/10.1158/2159-8290.CD-21-0177
Wu, Hsin-Chieh, et al. "Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy." Cancer discovery vol. (2021). doi: https://doi.org/10.1158/2159-8290.CD-21-0177
Wu HC, Rérolle D, Berthier C, Hleihel R, Sakamoto T, Quentin S, Benhenda S, Morganti C, Wu C, Conte L, Rimsky S, Sebert M, Clappier E, Souquere S, Gachet S, Soulier J, Durand S, Trowbridge JJ, Bénit P, Rustin P, Hajj HE, Raffoux E, Ades L, Itzykson R, Dombret H, Fenaux P, Espeli O, Kroemer G, Brunetti L, Mak TW, Lallemand-Breitenbach V, Bazarbachi A, Falini B, Ito K, Martelli MP, de Thé H. Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy. Cancer Discov. 2021 Jul 23; doi: 10.1158/2159-8290.CD-21-0177. Epub 2021 Jul 23. PMID: 34301789.
Copy Download .nbib Format: NLM
360° Ab-Interno Schlemm's Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma-Midterm Results.

Journal of clinical medicine

Toneatto G, Zeppieri M, Papa V, Rizzi L, Salati C, Gabai A, Brusini P.
PMID: 35012000
J Clin Med. 2022 Jan 04;11(1). doi: 10.3390/jcm11010259.

PURPOSE: To evaluate the effectiveness of ab-interno microcatheterization and 360° viscodilation of Schlemm's canal (SC) performed with OMNI viscosurgical system in open angle glaucoma (OAG) together or not with phacoemulsification.SETTING: Two surgical sites.DESIGN: Retrospective, observational.METHODS: Eighty eyes from 73...

Cite
Toneatto G, Zeppieri M, Papa V, et al. 360° Ab-Interno Schlemm's Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma-Midterm Results. J Clin Med. 2022;11(1)doi: 10.3390/jcm11010259.
Toneatto, G., Zeppieri, M., Papa, V., Rizzi, L., Salati, C., Gabai, A., & Brusini, P. (2022). 360° Ab-Interno Schlemm's Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma-Midterm Results. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010259
Toneatto, Giacomo, et al. "360° Ab-Interno Schlemm's Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma-Midterm Results." Journal of clinical medicine vol. 11,1 (2022). doi: https://doi.org/10.3390/jcm11010259
Toneatto G, Zeppieri M, Papa V, Rizzi L, Salati C, Gabai A, Brusini P. 360° Ab-Interno Schlemm's Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma-Midterm Results. J Clin Med. 2022 Jan 04;11(1). doi: 10.3390/jcm11010259. PMID: 35012000; PMCID: PMC8745878.
Copy Download .nbib Format: NLM
Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma.

Clinical case reports

Dubois S, Ruminy P, Bohers E, Viailly PJ, Veresezan L, Picquenot JM, Bobée V, Viennot M, Penther D, Camus V, Thieblemont C, Pouaty C, Tilly H, Jardin F.
PMID: 34429980
Clin Case Rep. 2021 Aug 16;9(8):e04504. doi: 10.1002/ccr3.4504. eCollection 2021 Aug.

Synchronous Hodgkin Lymphoma and Primary Mediastinal B-cell Lymphoma is possible, with molecular analyses proving the absence of clonal filiation between both entities. This suggests a common etiology but the existence of two divergent clones.

Cite
Dubois S, Ruminy P, Bohers E, et al. Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma. Clin Case Rep. 2021;9(8):e04504doi: 10.1002/ccr3.4504.
Dubois, S., Ruminy, P., Bohers, E., Viailly, P. J., Veresezan, L., Picquenot, J. M., Bobée, V., Viennot, M., Penther, D., Camus, V., Thieblemont, C., Pouaty, C., Tilly, H., & Jardin, F. (2021). Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma. Clinical case reports, 9(8), e04504. https://doi.org/10.1002/ccr3.4504
Dubois, Sydney, et al. "Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma." Clinical case reports vol. 9,8 (2021): e04504. doi: https://doi.org/10.1002/ccr3.4504
Dubois S, Ruminy P, Bohers E, Viailly PJ, Veresezan L, Picquenot JM, Bobée V, Viennot M, Penther D, Camus V, Thieblemont C, Pouaty C, Tilly H, Jardin F. Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma. Clin Case Rep. 2021 Aug 16;9(8):e04504. doi: 10.1002/ccr3.4504. eCollection 2021 Aug. PMID: 34429980; PMCID: PMC8365538.
Copy Download .nbib Format: NLM
Showing 193 to 199 of 199 entries